Clinical Trial Update: Effects of Vildagliptine and Glimepiride on Glucose Variability [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the combination of vildagliptin and glimepiride for affecting glucose variability in adults with Type 2 diabetes mellitus. The study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Galvus (vildagliptin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 4 | Status: COMPLETED